Tomohiro Murata

Real-world use of dotinurad and one-year prescription presence by kidney function in older adults

Evidence on dotinurad, a selective urate transporter 1 inhibitor, in older adults with reduced kidney function is limited. We conducted a retrospective cohort study using the Japan Medical Data Center elderly claims database from April 2021 to February 2023 to describe real-world...